Join now & save up to 80% on medication

JOIN NOW
Select Language:

Join now and save 80% on medication

Register/Login

Insulin Degludec Vs. Insulin Glargine

Share Post:

What is insulin glargine?

Insulin glargine, also known by the brand name Lantus, is a long-lasting basal insulin analog that is taken once per day to help control blood sugar levels in those suffering from diabetes. It gradually secretes insulin, so its effects last between 18 and 26 hours. Its effects on the body are similar to those of basal insulin in non-diabetic pancreatic beta cells. It may also be used in combination with a fast-acting insulin.

What is insulin degludec?

Insulin degludec is an ultra-long-acting basal insulin analog that is approved for use in adults with type 1 and type 2 diabetes. It is administered by injection once per day to help control the blood sugar levels of those with diabetes. The effects of insulin degludec last up to 42 hours. This insulin is also marketed under the name Tresiba.

Differences and similarities between insulin glargine and insulin degludec

Differences

Tresiba, although a popular insulin, was only released back in 2016. Lantus, on the other hand, was released in 2000. While Tresiba is also slightly more expensive compared to Lantus, it is also 50% less likely to cause hypoglycemia. Compared to insulin glargine, insulin degludec also proved to be more predictable in controlling blood sugar. Insulin glargine, however, can lower A1c by up to 2 to 3%. Lantus is also considered safe for use in people with kidney or liver problems.

Similarities

Both insulin medications may cause slight weight gain. Both Lantus and Tresiba are injectable drugs and you must monitor your blood sugar regularly. Dosing with either medication is easy to customize and should be taken once daily.


Disclaimer: Please note that the contents of this community article are strictly for informational purposes and should not be considered as medical advice. This article, and other community articles, are not written or reviewed for medical validity by Canadian Insulin or its staff. All views and opinions expressed by the contributing authors are not endorsed by Canadian Insulin. Always consult a medical professional for medical advice, diagnosis, and treatment.
Profile image of CDI Staff Writer

Written by CDI Staff WriterOur internal team are experts in many subjects. on May 5, 2022

Related Articles

Diabetes, Diabetes Supplies,
Lantus Vial: Long-Lasting Insulin for Stability

Effectively managing diabetes requires a consistent and effective insulin regimen. The Lantus vial is a widely used long-acting insulin that provides steady blood sugar control for up to 24 hours.…

Read More
Diabetes, Diabetes Supplies,
Humalog Vial: Rapid Insulin for Post-Meal Control

For individuals managing diabetes, keeping blood sugar levels stable is a top priority. Post-meal glucose spikes can be challenging to control, leading to fluctuations that may impact overall health. That’s…

Read More
Diabetes, General Health,
Avoid These Common Diabetes Mistakes, Says Leading Expert in the U.S.

Diabetes management can be challenging, but understanding and avoiding common mistakes can significantly improve your health and quality of life. According to a leading diabetes expert in the U.S., there…

Read More
Diabetes, Diabetes Supplies,
What Determines Basaglar Insulin Price? Key Factors You Need to Know

Summary: The Basaglar insulin price is shaped by production complexity, regulatory costs, and market competition. Insurance coverage, PBMs, and economic factors also affect the final cost. Recognizing these elements can…

Read More